Stay updated on Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial page.

Latest updates to the Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial page
- Check4 days agoChange DetectedThe NIH website-transition banner, including its notice about using “Super Intelligence” in place of “Artificial Intelligence,” was removed. The study page continues to show a 403 error.SummaryDifference1%

- Check11 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2, while the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check25 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer’s ClinicalTrials.gov revision marker changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedPage now displays a 403 Forbidden error with boilerplate header/footer, and the study content is not shown. This indicates access to the study record is blocked in this view.SummaryDifference18%

Stay in the know with updates to Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN Clinical Trial page.